¼¼°èÀÇ ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå : »ç¿ë¹ýº°, ±â¼úº°, Åõ¿© °æ·Îº°, Ä¡·á ºÐ¾ßº°, ¿ë·®º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - ¿¹Ãø(-2030³â)
Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030
»óǰÄÚµå : 1674549
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 384 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 7,024,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,650 £Ü 9,437,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,150 £Ü 11,565,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,191,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå ±Ô¸ð´Â 2024³â 14¾ï ´Þ·¯¿¡¼­ 2030³â 30¾ï 2,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CAGRÀº 13.6%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¿ÀÅäÀÎÁ§ÅÍ ÃÖÁ¾ Á¦Á¦ ½ÃÀåÀº 2024³â 673¾ï ´Þ·¯¿¡¼­ 2030³â 1,342¾ï 7,000¸¸ ´Þ·¯¿¡ À̸£°í, ¿¬Æò±Õ 12.2% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó ¿¬µµ 2022-2030³â
±âÁØ ¿¬µµ 2023³â
¿¹Ãø ±â°£ 2024-2030³â
´ë»ó ´ÜÀ§ ±Ý¾×(USD) ¹× ¼ö·®(°³)
ºÎ¹® ¿ëµµº°, ±â¼úº°, Åõ¿©°æ·Îº°, Ä¡·á ºÐ¾ßº°, ¿ë·®º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
´ë»ó Áö¿ª ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

±â¼úº°·Î ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀåÀº ¼öµ¿°ú ÀÚµ¿À¸·Î ¼¼ºÐÈ­µË´Ï´Ù. ¼öµ¿ ¿ÀÅäÀÎÁ§ÅÍ ºÎ¹®Àº ´ç´¢º´, ´Ù¹ß¼º °æÈ­Áõ, ·ù¸¶Æ¼½º °üÀý¿° µîÀÇ Áúº´ À¯º´·ü Áõ°¡·Î ÀÎÇÑ ¼ö¿ä Áõ°¡·Î 2023³â ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ºñ¿ë È¿À²¼º°ú »õ·Î¿î Ä¡·á ¿ëµµÀÇ È®´ë·Î ÀÎÇØ ¼öµ¿½Ä ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå ÀáÀç·ÂÀº ÇâÈÄ ¸î ³âµ¿¾È Àü¹ÝÀûÀ¸·Î »ó½ÂÇÒ °¡´É¼ºÀÌ ³ôÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ÀÅäÀÎÁ§ÅÍ ½ÃÀåÀÇ ÃÖÁ¾ »ç¿ëÀÚ ºÎ¹®Àº ÀçÅÃÄ¡·á ÇöÀå, º´¿ø ¹× Ŭ¸®´Ð, ¿Ü·¡ Áø·á ȯ°æÀ¸·Î ±¸ºÐµÇ¸ç, 2023³â¿¡´Â ÀçÅÃÄ¡·á ÇöÀå¿¡¼­ÀÇ ¿ÀÅäÀÎÁ§ÅÍ Ã¤Åà Áõ°¡·Î ÀÎÇØ ÀçÅÃÄ¡·á ÇöÀå ºÎ¹®ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ºñ¿ë È¿À²ÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÚµ¿ ÁÖ»ç±â ÀåÄ¡ÀÇ Ãâ½Ã´Â ÀçÅÃÄ¡·á ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ¾Æ³ªÇʶô½Ã½º ¹ÝÀÀ°ú °°Àº ÀÀ±Þ»óȲ¿¡ ´ëÇÑ ÀÚµ¿ÁÖ»ç±â »ç¿ëÀº º´¿ø ¹× Ŭ¸®´Ð¿¡¼­ ÀÚµ¿ÁÖ»ç±â ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì´Â 2023³â ÀÚµ¿ÁÖÀԱ⠽ÃÀåÀ» Àå¾ÇÇÏ°í ¿¹Ãø ±â°£ µ¿¾È °è¼Ó Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹ß´ÞµÈ ÀÇ·á ÀÎÇÁ¶ó, ´ç´¢º´, ·ù¸¶Æ¼½º °üÀý¿°, ´Ù¹ß¼º °æÈ­Áõ°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯Çà, ºÏ¹ÌÀÇ À¯¸®ÇÑ »óȯ Á¤Ã¥ µîÀÌ ¿ÀÅäÀÎÁ§ÅÍ »ç¿ë¿¡ ¿µÇâÀ» ¹ÌÄ¡¸ç ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀåÀº 2024-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀº ´Ù¼öÀÇ Á¦¾à»ç ¹× ¹ÙÀÌ¿À Á¦¾à»çÀÇ Á¸Àç¿Í ƯÈ÷ Áß±¹, Àεµ, Çѱ¹¿¡¼­ÀÇ ¿ÀÅäÀÎÁ§ÅÍ¿¡ ´ëÇÑ ±ÔÁ¦ ½ÂÀÎ °Ç¼ö°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.

¼¼°èÀÇ ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ¿ëµµº°/±â¼úº°/Åõ¿©°æ·Îº°/Ä¡·á ºÐ¾ßº°/¿ë·®º°/ÃÖÁ¾»ç¿ëÀÚº°/Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ÇÁ¸®¹Ì¾ö ÀλçÀÌÆ®

Á¦5Àå ½ÃÀå °³¿ä

Á¦6Àå ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå, »ç¿ë¹ýº°

Á¦7Àå ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå, ±â¼úº°

Á¦8Àå ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå, Åõ¿©°æ·Îº°

Á¦9Àå ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå, Ä¡·á ºÐ¾ßº°

Á¦10Àå ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå, ¿ë·®º°

Á¦11Àå ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°

Á¦12Àå ¿ÀÅäÀÎÁ§ÅÍ ½ÃÀå, Áö¿ªº°

Á¦13Àå °æÀï ±¸µµ

Á¦14Àå ±â¾÷ °³¿ä

Á¦15Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global autoinjectors market is projected to to expand to a value of USD 3.02 billion in 2030 from USD 1.40 billion in 2024, with a significant CAGR of 13.6%. The autoinjector finished formulations market is projected to surge to a value of USD 134.27 billion in 2030 from USD 67.30 billion in 2024, growing at a CAGR of 12.2%.

Scope of the Report
Years Considered for the Study2022-2030
Base Year2023
Forecast Period2024-2030
Units ConsideredValue (USD) and Volume (Unit)
SegmentsUsage, Technology, Route of Administration, Therapy Area, Volume, and End user
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Favorable reimbursement policies in North America and Europe coupled with launch of biosimilars across the globe are some of the factors contributing towards the market growth.

"The manual autoinjectors segment accounted for the largest share in 2023."

On the basis of technology, the autoinjectors market is further segmented into manual, and automatic. The manual autoinjectors segment dominated the market in 2023, owing to the rise in demand due to rising incidence of conditions such as diabetes, multiple sclerosis, and rheumatoid arthritis. Furthermore, cost-effectiveness and expanding new therapeutic applications, is likely to increase their overall market potential for manual autoinjectors in coming years.

"By end user, the home care settings segment accounted for the largest share in the autoinjectors market."

The end user segment in the autoinjectors market is segmented into home care settings, hospitals & clinics, and ambulatory care settings. In 2023, the home care settings segment accounted for the largest share owing to increased adoption of autoinjectors at home care settings. Furthermore, cost effectiveness, launch of user friendly autoinjector devices is likely to boost the growth of the home care settings segment. Use of autoinjectors for emergency situations such as anaphylactic reactions is likely to increase demand for autoinjectors in hospitals & clinics further propelling the growth of the market.

"North America: the largest share of the autoinjectors market"

North America dominated the autoinjectors market in 2023 and likely continue dominance during the forecast period. Well-developed healthcare infrastructure, prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and multiple sclerosis and favourable reimbursement policies in North America are some of the factors influencing the use of autoinjectors subsequently contributing towards market growth. The Asia Pacific autoinjectors market is predicted to grow at the significant CAGR during the forecast period of 2024-2030. The growth of the region is primarily attributed to the presence of large number of pharmaceutical and biopharmaceutical companies and growing number of regulatory apporvals for autoinjectors in the region especially China, India and South Korea.

The primary interviews conducted for this report can be categorized as follows:

List of Companies Profiled in the Report:

Research Coverage:

This research report categorizes the autoinjectors market usage (reusable and disposable), technology (manual and automatic), route of administration (intramuscular and subcutaneous), therapy area (rheumatoid arthritis, multiple sclerosis, anaphylaxis, diabetes, obesity and other therapy areas), Volume (upto 3ml and above 3 ml) and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the autoinjectors market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the autoinjectors market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the autoinjector devices and finished formulations market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 AUTOINJECTORS MARKET, BY USAGE

7 AUTOINJECTORS MARKET, BY TECHNOLOGY

8 AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION

9 AUTOINJECTORS MARKET, BY THERAPY AREA

10 AUTOINJECTORS MARKET, BY VOLUME

11 AUTOINJECTORS MARKET, BY END USER

12 AUTOINJECTORS MARKET, BY REGION

13 COMPETITIVE LANDSCAPE

14 COMPANY PROFILES

15 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â